Peter S. Linsley

Molecular Biology · Nature · 2001–2010

A researcher in the Science corpus: 16 papers; trusts 13 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 171 citations into it; #10,856 of 17,773 by trust here, #553 by citations
• Cancer Research — 121 citations into it; #867 of 1,780 by trust here, #79 by citations

Whom Peter S. Linsley trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Isaac Bentwich
2. Benjamin P. Lewis
3. Lee P. Lim
4. A. Jackson
5. David P. Bartel
6. Praveen Sethupathy
7. George A. Calin
8. Bino John
9. A. Krek
10. Alexander Stark

Who trusts Peter S. Linsley overall

1. Vikram Agarwal
2. Galina Gabriely
3. Marshall P. Thomas
4. Sean E. McGeary

Papers from Peter S. Linsley's perspective

Ordered by how strongly the researchers Peter S. Linsley trusts endorse each paper. Same corpus, a different order for every researcher.

1. Specificity of microRNA target selection in translational repression. (Genes & Development)
2. The microRNAs of Caenorhabditis elegans. (Genes & Development)
3. MicroRNA-Directed Cleavage of HOXB8 mRNA (Science)
4. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs (Nature reviews genetics)
5. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.
6. The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution (Science)
7. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals (Nature)
8. Prediction of plant microRNA targets. (Cell)
9. Combinatorial microRNA target predictions (Nature Genetics)
10. Silencing of microRNAs in vivo with ‘antagomirs’ (Nature)

Their papers

• Expression profiling reveals off-target gene regulation by RNAi (2003) — 2,462 citations
• Gene expression profiling predicts clinical outcome of breast cancer (2002) — 9,976 citations
• Experimental annotation of the human genome using microarray technology (2001) — 469 citations
• Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer (2001) — 1,364 citations
• Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression (2007) — 600 citations
• Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. (2006) — 817 citations
• Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. (2006) — 1,004 citations
• Minimizing the risk of reporting false positives in large-scale RNAi screens (2006) — 480 citations
• Genetics of gene expression surveyed in maize, mouse and man (2003) — 1,578 citations
• A microRNA component of the p53 tumour suppressor network (2007) — 2,843 citations
• MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators (2008) — 926 citations
• Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application (2010) — 1,078 citations
• Gene expression changes associated with progression and response in chronic myeloid leukemia. (2006) — 609 citations
• Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties (2005) — 711 citations
• Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs (2005) — 4,962 citations
• CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms (2004) — 1,879 citations